Biohaven Ltd. (BHVN) ROA
- 2026-06-30: ROA -158.29%.
- 2026-03-31: ROA -138.87%.
- 2025-12-31: ROA -163.66%.
- 2025-09-30: ROA -190.68%.
Complete source-backed roa history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -158.29% |
| 2026-03-31 | -138.87% |
| 2025-12-31 | -163.66% |
| 2025-09-30 | -190.68% |
| 2025-06-30 | -139.34% |
| 2025-03-31 | -193.62% |
| 2024-12-31 | -137.61% |
| 2024-09-30 | -157.55% |
| 2024-06-30 | -128.14% |
| 2024-03-31 | -123.57% |
| 2023-12-31 | -79.53% |
| 2023-09-30 | -121.37% |
| 2023-06-30 | -85.01% |
| 2023-03-31 | -87.91% |
| 2022-12-31 | -86.17% |
| 2022-09-30 | -310.41% |
| 2021-12-31 | -150.50% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -163.66% |
| 2024-12-31 | -137.61% |
| 2023-12-31 | -79.53% |
| 2022-12-31 | -86.17% |
| 2021-12-31 | -150.50% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |